Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial - Sun, Ying; Li, Wen-Fei; Chen, Nian-Yong; Zhang, Ning; Hu, Guo-Qing; Xie, Fang-Yun; Sun, Yan; Chen, Xiao-Zhong; Li, Jin-Gao; Zhu, Xiao-Dong; Hu, Chao-Su; Xu, Xiang-Ying; et al. (The lancet oncology, 2016)
Keywords: Adult; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Carcinoma; Chemoradiotherapy - adverse effects; Chemotherapy; Cisplatin - administration & dosage; Docetaxel; Female; Fluorouracil - administration & dosage; Head & neck cancer; Hematology; Hematology, Oncology and Palliative Medicine; Humans; Induction Chemotherapy - adverse effects; Male; Medical prognosis; Metastasis; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms - mortality; Nasopharyngeal Neoplasms - therapy; Neutropenia; Radiation therapy; Studies; Taxoids - administration & dosage